• Capacity Constraints Continue to Loosen for Suzhou Erye Pharmaceuticals Company Ltd. as a New Production Line is Approved by the China SFDA More...

• Edison Pharmaceuticals, Inc. Announces Results of EPI-A0001 Phase 2A Double Blind Placebo Controlled 28-Day Clinical Trial in the Mitochondrial Disease- Friedreich's Ataxia More...

• Circassia Limited's Rapid Four-Dose ToleroMune® Treatment Maintains Significant Reduction in Allergy Symptoms During 12-Month Follow-up More...

• Ambit Biosciences Release: Interim Data from Phase 2 Trial of AC220 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia with FLT3-ITD Activating Mutations More...

• Dong-A PharmTech and Dr. Falk Pharma GmbH Announce Positive Data in Portal Hypertension With Udenafil More...

• CytRx Corporation (CYTR) Reports Positive Preliminary Results from ENABLE Phase 2 Clinical Trial with Bafetinib in Patients with Relapsed B-Cell Chronic Lymphocytic Leukemia More...



• Breastfeeding Linked to Lower Risk of SIDS, University of Virginia Study More...

• Scientists Identify Three Genes Linked wth Migraine, Women Three Times More Likely to Suffer, Harvard University Study Finds More...

• Alexion Pharmaceuticals Inc. (ALXN) Release: New Data Show Renal Impairment Is Strong Predictor of Early Death in Patients with PNH More...

• ViroPharma Incorporated (VPHM) Release: Nine Abstracts Relating to Cinryze® (C1 Esterase Inhibitor [human]) Data Presented at 30th Congress of the European Academy of Allergy and Clinical Immunology (EAACI) More...

• St. Jude Children's Research Hospital Release: Researchers Improve Method For Finding Genetic Mistakes That Fuel Cancer More...

• U.S. Investigates Gilead Sciences, Inc. (GILD)'s Drug Manufacturing And Distribution Practices More...

• Abbott Laboratories (ABT) Release: Drug Humira Causes Veteran's Near Death and Debilitating Fungal Infection More...

• Millennium Pharmaceuticals, Inc. (South San Francisco, California) (MLNM) Announces $13 Million Equity Financing More...

• Merck & Co., Inc. (MRK) Buys Hanwha Drug-Marketing Rights for $720 Million More...

• Synageva BioPharma Nabs Trimeris, Inc. (TRMS) in All-Stock Deal More...

• Actelion Ltd. (ALIOF.PK) Sale Possible If New Drug Fails More...

• inVentiv Health (VTIV) Completes Acquisition of i3 (Newton, Massachusetts) More...

• Vertex Pharmaceuticals (MA) (VRTX) in Licensing Pact Potentially Worth $1.5 Billion With Alios BioPharma to Expand Hepatitis Pipeline More...

• Kareus Therapeutics Enters Strategic Drug Development Alliance With Quintiles, Inc. (QTRN) More...

• Cortex Pharmaceuticals, Inc. (COR) Enters into New Agreement with Servier; Cortex Could Possibly Receive $3 Million More...

• Unigene Laboratories, Inc. (UGNE) Continues Solid Execution of Focused Turnaround Strategy and Monetizes Non-Core Asset with the Termination of China Joint Venture with China Pharmaceutical Group Limited More...

• ISPE Announces Partnership with US Environmental Protection Agency'sENERGY STAR Program More...

• Carl Icahn Wants Four Seats on Forest Laboratories, Inc. (FRX)'s Board More...

• Tetragenetics Announces New CEO and Expands Board of Directors More...

• Tibet Pharmaceuticals Announces New CEO More...

• Spectrum Pharmaceuticals, Inc. (SPPI) Announces Promotions of Steven M. Fruchtman, MD, to Chief Medical Officer, Head of Medical & Regulatory Affairs, and Nozar Azarnia, PhD, to Head of Biostatistics and Data ManagementMore...

• e-Therapeutics plc Appoints Daniel Elger as Chief Financial Officer More...

• U.S. Investigates Gilead Sciences, Inc. (GILD)'s Drug Manufacturing And Distribution Practices More...

• Abbott Laboratories (ABT) Release: Drug Humira Causes Veteran's Near Death and Debilitating Fungal Infection More...

• UTSA Receives $4.6 Million to Create Center of Excellence in Infection Genomics More...